Study demonstrates anti-prostate cancer properties of Modified Citrus Pectin

[News]

Researchers at Columbia University recently analyzed the positive effects of Modified Citrus Pectin (MCP) on human and mouse prostate cancer cell lines. The results, as reported by lead researcher Dr. Aaron Katz in the publication of Integrative Cancer Therapies, show that MCP inhibits cell proliferation and induces apoptosis (programmed cell death) in both androgen-dependent and androgen-independent cancer cells in a time and dose-dependent manner.

More... (http://www.news-medical.net/news/20101021/Study-demonstrates-anti-prostate-cancer-properties-of-Modified-Citrus-Pectin.aspx)